From: A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
PRIMARY
RECURRENCE
Negative
Negative Polysomic
Low Amplified
High Amplified
53
11
0
9
6
0 (2*)
2
5
1
26